Japan, Sept. 16 -- SUNSTAR INC has got intellectual property rights for 'ORAL COMPOSITION.' Other related details are as follows:

Application Number: JP,2022-076086

Category (FI): A61K47/14,A61Q11/00,A61P1/02,A61K8/73,A61K6/58,A61K47/38,A61K6/60,A61K6/69,A61K8/49,A61K31/4425,A61K8/86

Stage: PROBLEM TO BE SOLVED: To suppress the disproportionation of cetylpyridinium chloride hydrate (CPC) even with a relatively high level of the CPC.SOLUTION: An oral composition contains cetylpyridinium chloride hydrate of 0.1 mass% or more, and further contains polyoxyethylene hydrogenated castor oil with an average number of added moles of ethylene oxide ranging from 35 to 45, and polyoxyethylene sorbitan stearate.SELECTED DRAWING: None (Grant)

Filing ...